Author:
Mackey Tim K.,Liang Bryan A.
Reference5 articles.
1. After Amarin v FDA: What will the future hold for off-label promotion regulation?;Mackey;Mayo Clin Proc,2016
2. Regulating off-label promotion—a critical test;Robertson;N Engl J Med,2016
3. Promotion of drugs for off-label uses: the US Food and Drug Administration at a crossroads;Kim;JAMA Intern Med,2017
4. Off-label promotion reform: a legislative proposal addressing vulnerable patient drug access and limiting inappropriate pharmaceutical marketing;Mackey;Univ Mich J Law Reform,2011
5. Reforming off-label promotion to enhance orphan disease treatment;Liang;Science,2010